HR. 10150In Committee
To amend the Federal Food, Drug, and Cosmetic Act to provide a period of market exclusivity for botanical drugs, and for other purposes.
Summary not available yet.
Plain-English overview
What this bill does
A plain-English summary is not available for this bill yet.
Current status
Where it stands
Status
In Committee
Latest action
2026-08-27 — Referred to the House Committee on Energy and Commerce.
Related context
Topics and policy areas
undefined